Carl Zeiss Meditec AG (AFX)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

€40.26

Buy

€40.60

arrow-up€0.00 (+0.00%)

Prices updated at 12 Dec 2025, 19:10 CET
| Prices minimum 15 mins delay
|
Prices in EUR

Carl Zeiss Meditec AG offers end-to-end solutions for the diagnosis and treatment of ophthalmic diseases, including implants and consumables. It provides visualization solutions in microsurgery. It offers its solutions to physicians and hospitals.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Andreas Pecher
CEO
-
Most recent earnings
30 Sep 2025
Fiscal year end
30 Sep 2025
Employees
5,784
Head office
Goschwitzer Strasse 51-52
Jena
Germany
07745
mobile
+49 3641220115
letter
-

Key personnel

Salary
Mr. Stefan Muller
Member of the Supervisory Board
-
Mr. Torsten Reitze
Member of the Supervisory Board
-
Ms. Isabel De Paoli
Member of the Supervisory Board
-
Mr. Peter Kameritsch
Member of the Supervisory Board
-
Mr. Rene Denner
Deputy Chairman of the Supervisory Board
-
Mr. Jeffrey Marx
Member of the Supervisory Board
-
Ms. Brigitte Koblizek
Member of the Supervisory Board
-
Mr. Falk Bindheim
Member of the Supervisory Board
-
Ms. Heike Madan
Member of the Supervisory Board
-
Dr. Christian Munster
Member of the Supervisory Board
-
Mr. Andreas Pecher
Chairman of the Supervisory Board
-

Top 5 shareholders

No. of shares
Capital Research and Management Company2,928,431
American Funds SMALLCAP World Fund2,601,687
Invesco International Small-Mid Cap1,585,381
Invesco International Smalll-Mid Company1,274,517
Union Investment Privatfonds GmbH1,216,464

Director dealings

Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.